Bellerophon Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q1 2017 to Q3 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2017 to Q3 2023.
  • Bellerophon Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2023 was -0.16 USD/shares, a 69.8% increase year-over-year.
  • Bellerophon Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2023 was -0.84 USD/shares, a 57.8% increase year-over-year.
  • Bellerophon Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.08 USD/shares, a 11.2% decline from 2021.
  • Bellerophon Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -1.87 USD/shares, a 41% increase from 2020.
  • Bellerophon Therapeutics, Inc. annual Earnings Per Share, Basic for 2020 was -3.17 USD/shares, a 7.46% decline from 2019.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$1 $0 +$0.37 +69.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$1 $0 +$0.01 +2.33% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$1 $0.27 +$0.86 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$2 -$1 $0 -20.5% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$2 -$1 $0 -8.16% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$2 $0 $0 -19.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$2 -$1 $0 -1.72% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$2 $0 +$0.40 +47.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$2 $0 +$0.35 +41.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3 $0 +$0.15 +29.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$3 -$1 +$0.50 +46.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$3 -$1 +$0.05 +5.62% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$3 -$1 +$0.10 +10.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$3 -$1 +$0.39 +43.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$4 -$1 -$1 -500% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$3 -$1 -$1 -271% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$2 -$1 -$4 -133% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 $1.57 -$1 +$2.11 +70.1% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 -$1 $0 -$1 -117% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 $0.72 $0 +$0.20 +45.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-06
Q3 2018 $0.52 $2.89 +$3.11 Jul 1, 2018 Sep 30, 2018 10-K 2020-04-06
Q2 2018 -$3 -$3 -$3 -2408% Apr 1, 2018 Jun 30, 2018 10-K 2020-04-06
Q1 2018 $0.30 $1.08 +$1.68 Jan 1, 2018 Mar 31, 2018 10-K 2020-04-06
Q4 2017 -$1 $0 Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 -$1 Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.